Compile Data Set for Download or QSAR
Report error Found 44 Enz. Inhib. hit(s) with all data for entry = 11329
TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608104(US11691968, Example 134)
Affinity DataIC50: 4nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608079(US11691968, Example 63)
Affinity DataIC50: 10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608078(US11691968, Example 62)
Affinity DataIC50: 10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608102(US11691968, Example 131)
Affinity DataIC50: 10nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608065(US11691968, Example 1 | [(1R,5S,6r)-6-(5,5-dimethy...)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608089(US11691968, Example 85 | (1-cyclopropyl-1H-imidazo...)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608085(US11691968, Example 77)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608080(US11691968, Example 65)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608076(US11691968, Example 59)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608073(US11691968, Example 51 | (1-cyclopropyl-1H-imidazo...)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608074(US11691968, Example 55)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608107(US11691968, Example 144)
Affinity DataIC50: 20nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608094(US11691968, Example 96)
Affinity DataIC50: 30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608071(US11691968, Example 33 | [(1R,5S,6r)-6-(5,5-dimeth...)
Affinity DataIC50: 30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608081(US11691968, Example 66)
Affinity DataIC50: 30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608088(US11691968, Example 84)
Affinity DataIC50: 30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608087(US11691968, Example 82 | (1-cyclopropyl-1H-imidazo...)
Affinity DataIC50: 30nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608096(US11691968, Example 104)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608097(US11691968, Example 106)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608090(US11691968, Example 87)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608100(US11691968, Example 121)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608101(US11691968, Example 124)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608103(US11691968, Example 132)
Affinity DataIC50: 40nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608098(US11691968, Example 110)
Affinity DataIC50: 50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608092(US11691968, Example 90)
Affinity DataIC50: 50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608105(US11691968, Example 136)
Affinity DataIC50: 50nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608067(US11691968, Example 12 | {1-[(2S)-butan-2-yl]-1H-i...)
Affinity DataIC50: 60nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608086(US11691968, Example 81 | [(1R,5S,6r)-6-(5,5-dimeth...)
Affinity DataIC50: 60nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608084(US11691968, Example 76)
Affinity DataIC50: 60nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608091(US11691968, Example 88 | [(1R,5S,6r)-6-(5,5-dimeth...)
Affinity DataIC50: 70nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608108(US11691968, Example 145)
Affinity DataIC50: 90nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608095(US11691968, Example 103)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608093(US11691968, Example 93)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608082(US11691968, Example 69)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608077(US11691968, Example 60)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608075(US11691968, Example 56)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608072(US11691968, Example 40)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608069(US11691968, Example 24)
Affinity DataIC50: 200nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608099(US11691968, Example 119)
Affinity DataIC50: 300nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608083(US11691968, Example 75)
Affinity DataIC50: 400nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608068(US11691968, Example 22)
Affinity DataIC50: 400nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608066(US11691968, Example 9)
Affinity DataIC50: 400nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608106(US11691968, Example 138)
Affinity DataIC50: 800nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent

TargetLysine-specific demethylase 5A(Human)
Ono Pharmaceutical

US Patent
LigandPNGBDBM608070(US11691968, Example 27)
Affinity DataIC50: 1.00E+3nMAssay Description:Using 384-well white Greiner784075 (Greiner), representative compounds were characterized for their inhibition of KDM5A using HTRF technology (Cisbio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/6/2023
Entry Details
Go to US Patent